Logo.png
Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update
16 nov. 2021 09h58 HE | Protagenic Therapeutics, Inc.
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders,...
Changing the Way the World Thinks About Eating Disorders - A Free Webinar from the Brain & Behavior Research Foundation
21 nov. 2019 09h00 HE | Brain & Behavior Research Foundation
New York, Nov. 21, 2019 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation is hosting a free webinar “Changing the Way the World Thinks About Eating Disorders” on Tuesday, December 10,...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Appoints James Sapirstein as Executive Vice Chairman of the Board of Directors
03 janv. 2019 08h45 HE | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J, Jan. 03, 2019 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a clinical stage pharmaceutical company, focused on the development of...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces Publication of Ampakine Data:
25 juil. 2018 09h00 HE | RespireRX Pharmaceuticals Inc.
Effects of Chronic Systemic Low-impact Ampakine Treatment on Neurotrophin Expression in Rat Brain Glen Rock, N.J., July 25, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI)...
Logo Blue Main.png
Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology
14 nov. 2017 07h00 HE | Neuronascent, Inc.
CLARKSVILLE, Md., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Neuronascent, Inc. (www.neuronascent.com), a biopharmaceutical company focused on oral therapeutics to promote neuron regeneration, today...
Nobilis_logo_vertical_preview.jpg
Nobilis Therapeutics Receives a Notice of Allowance for a Patent Covering Treatment of Psychiatric Disorders With Noble Gases
12 juin 2017 18h57 HE | Nobilis Therapeutics, Inc.
PORTLAND, Ore., June 12, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics announced today that the patent that it had exclusively licensed from Partners HealthCare/McLean Hospital (an affiliate of...